a) Development of a vCJD blood bank screening test

Microsens is developing a blood test for use in routine screening applications based on the Seprion ligand technology, with a magnetic particle solid phase

b) Development of a CJD CSF and blood diagnostic test

Microsens has established a collaboration to co-develop a diagnostic test for CJD using cerebro-spinal fluid as the sample type. Capillary electrophoresis is used as the separation technique in this ultrasensitive assay

c) Development of a CJD diagnostic test for other tissues

Microsens is developing a Seprion ligand-based kit on the microplate format

d) Development of biomarker kits for neurodegenerative diseases

Microsens is developing kits for the detection of abnormal, aggregated proteins in Alzheimer’s, Parkinson’s, Huntingdon’s disease research in pharmaceutical drug discovery and scientific research